UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids

Phase 2

Completed

Conditions: Sleep
Chronic Pain
Obstructive Sleep Apnea
Pain
Sleep Apnea
Sleep Disorder
Sleep Disorder; Breathing-Related
Opioid Use

Interventions: Device: Positive Airway Pressure (PAP)

First Posted Date: 2021-06-16

Last Posted Date: 2024-12-02

Lead Sponsor: University of California, San Diego

Target Recruit Count: 62

Registration Number: NCT04928157

Locations: 🇺🇸
University of California San Diego, San Diego, California, United States

iPACK Block With Dexamethasone For Total Knee Replacement

Phase 4

Terminated

Conditions: Acute Pain
Regional Anesthesia
Anesthesia, Local
Knee Osteoarthritis

Interventions: Drug: ropivacaine 0.25% with epinephrine and 6mg dexamethasone
Drug: Saline

First Posted Date: 2021-06-08

Last Posted Date: 2023-11-07

Lead Sponsor: University of California, San Diego

Target Recruit Count: 14

Registration Number: NCT04917055

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States

Effect of Time-restricted Eating on Catecholamine-sensitivity of Adipose Tissue in Obese Adults

Not Applicable

Active, not recruiting

Conditions: Obesity

Interventions: Behavioral: Standard of Care
Behavioral: Time Restricted Eating

First Posted Date: 2021-06-07

Last Posted Date: 2024-01-24

Lead Sponsor: University of California, San Diego

Target Recruit Count: 61

Registration Number: NCT04916730

Locations: 🇺🇸
Altman Clinical and Translational Research Institute, La Jolla, California, United States

Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol

Not Applicable

Completed

Conditions: Posttraumatic Stress Disorder
Anxiety Disorders
Depression

Interventions: Behavioral: COGENT

First Posted Date: 2021-06-03

Last Posted Date: 2024-06-10

Lead Sponsor: University of California, San Diego

Target Recruit Count: 73

Registration Number: NCT04912089

Locations: 🇺🇸
UC San Diego, San Diego, California, United States

Defecation Patterns in Constipated Patients

Not Applicable

Suspended

Conditions: Constipation by Outlet Obstruction

Interventions: Drug: Atropin
Drug: Bisacodyl

First Posted Date: 2021-05-26

Last Posted Date: 2025-01-30

Lead Sponsor: University of California, San Diego

Target Recruit Count: 130

Registration Number: NCT04903470

Locations: 🇺🇸
University of California San Diego, La Jolla, California, United States

MIS-C Comparative Effectiveness Study

Phase 2

Active, not recruiting

Conditions: Multisystem Inflammatory Syndrome-Children

Interventions: Drug: Methylprednisolone
Drug: Infliximab
Drug: Anakinra

First Posted Date: 2021-05-24

Last Posted Date: 2024-09-27

Lead Sponsor: University of California, San Diego

Target Recruit Count: 73

Registration Number: NCT04898231

Locations: 🇺🇸
Rady Children's Hospital, San Diego, California, United States
🇺🇸
Children's Hospital Michigan, Detroit, Michigan, United States

Cannabis Use, Cognition, and the Endocannabinoid System in HIV

Early Phase 1

Recruiting

Conditions: HIV-1-infection

Interventions: Drug: 10 mg Δ9-tetrahydrocannabinol (THC)
Drug: 600 mg cannabidiol (CBD)
Drug: Placebo

First Posted Date: 2021-05-12

Last Posted Date: 2024-07-03

Lead Sponsor: University of California, San Diego

Target Recruit Count: 138

Registration Number: NCT04883255

Locations: 🇺🇸
UC San Diego Medical Center-Hillcrest, San Diego, California, United States

Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa

Early Phase 1

Active, not recruiting

Conditions: Anorexia Nervosa

Interventions: Drug: Cannabidiol
Drug: Placebo

First Posted Date: 2021-05-07

Last Posted Date: 2025-03-26

Lead Sponsor: University of California, San Diego

Target Recruit Count: 40

Registration Number: NCT04878627

Locations: 🇺🇸
University of California San Diego, San Diego, California, United States

Do Endotypes Predict Response and Sequelae in OSA Patients

Phase 2

Recruiting

Conditions: Sleep Apnea, Obstructive
Sleep
Obstructive Sleep Apnea
Sleep Apnea
Sleep Disorder

Interventions: Drug: Eszopiclone
Other: Supplemental Oxygen
Device: Continuous Positive Airway Pressure (CPAP)

First Posted Date: 2021-05-06

Last Posted Date: 2024-10-02

Lead Sponsor: University of California, San Diego

Target Recruit Count: 200

Registration Number: NCT04875364

Locations: 🇺🇸
Altman Clinical and Translational Research Institute Building, La Jolla, California, United States

Memantine Augmentation of Targeted Cognitive Training in Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Drug: Placebo
Drug: Memantine

First Posted Date: 2021-04-23

Last Posted Date: 2025-04-30

Lead Sponsor: University of California, San Diego

Target Recruit Count: 62

Registration Number: NCT04857983

Locations: 🇺🇸
Clinical Teaching Facility (CTF B-403 at UCSD Medical Center), San Diego, California, United States

Home Terms & Conditions Privacy Policy